F. Ajana

1.4k total citations
44 papers, 348 citations indexed

About

F. Ajana is a scholar working on Epidemiology, Infectious Diseases and Parasitology. According to data from OpenAlex, F. Ajana has authored 44 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Infectious Diseases and 8 papers in Parasitology. Recurrent topics in F. Ajana's work include Antifungal resistance and susceptibility (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Toxoplasma gondii Research Studies (5 papers). F. Ajana is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Toxoplasma gondii Research Studies (5 papers). F. Ajana collaborates with scholars based in France, Portugal and Spain. F. Ajana's co-authors include Y Mouton, Y Gérard, Didier Hober, É. Senneville, O. Leroy, J.M. Bourez, Christian Chidiac, Claude Bohuon, S. Alfandari and B Fortier and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Neurology Neurosurgery & Psychiatry and Journal of Antimicrobial Chemotherapy.

In The Last Decade

F. Ajana

40 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Ajana France 10 178 167 54 43 37 44 348
Wendy Ferguson Ireland 12 122 0.7× 120 0.7× 48 0.9× 35 0.8× 49 1.3× 22 335
Andrea Bedini Italy 14 221 1.2× 287 1.7× 85 1.6× 40 0.9× 68 1.8× 31 505
Manuela Avolio Italy 11 224 1.3× 101 0.6× 55 1.0× 37 0.9× 49 1.3× 34 419
Concha Amador Spain 10 290 1.6× 116 0.7× 43 0.8× 79 1.8× 92 2.5× 23 435
Sadako Yoshizawa Japan 13 146 0.8× 246 1.5× 18 0.3× 21 0.5× 35 0.9× 33 394
José A. Bazan United States 13 269 1.5× 128 0.8× 29 0.5× 73 1.7× 30 0.8× 44 587
J. Loutit United States 11 57 0.3× 85 0.5× 36 0.7× 57 1.3× 38 1.0× 16 364
J. Colaert Belgium 13 230 1.3× 115 0.7× 29 0.5× 53 1.2× 18 0.5× 33 376
Marco Libanore Italy 7 147 0.8× 196 1.2× 20 0.4× 12 0.3× 24 0.6× 11 312
H J Kolmos Denmark 8 185 1.0× 145 0.9× 52 1.0× 42 1.0× 21 0.6× 14 322

Countries citing papers authored by F. Ajana

Since Specialization
Citations

This map shows the geographic impact of F. Ajana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Ajana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Ajana more than expected).

Fields of papers citing papers by F. Ajana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Ajana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Ajana. The network helps show where F. Ajana may publish in the future.

Co-authorship network of co-authors of F. Ajana

This figure shows the co-authorship network connecting the top 25 collaborators of F. Ajana. A scholar is included among the top collaborators of F. Ajana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Ajana. F. Ajana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wyk, Jean van, F. Ajana, Fiona Bisshop, et al.. (2021). Switching to dolutegravir/lamivudine (DTG/3TC) fixed-dose combination (FDC) is non-inferior to continuing a tenofovir alafenamide (TAF)-based regimen (TBR) in maintaining virological suppression through 96 weeks (TANGO study). HIV Medicine. 22. 28–28.
2.
Alidjinou, Enagnon Kazali, Olivier Robineau, F. Ajana, et al.. (2017). RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients. Journal of Antimicrobial Chemotherapy. 72(10). 2823–2830. 29 indexed citations
3.
Bocket, Laurence, Gilles Peytavin, Enagnon Kazali Alidjinou, et al.. (2016). Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients. Journal of Antimicrobial Chemotherapy. 71(9). 2651–2653. 4 indexed citations
4.
Régnier, Faustine, F. Ajana, J Cheymol, et al.. (2014). Mise à jour des vaccinations de l’enfant arrivant de l’étranger (adopté, réfugié ou migrant) en France. Archives de Pédiatrie. 21(3). 329–334. 6 indexed citations
5.
Biekre, Raphaël, N. Viget, M. Valette, et al.. (2014). Long-term protection of hepatitis B vaccine in HIV-infected patients. BMC Infectious Diseases. 14(S2). 1 indexed citations
6.
Ettahar, N., et al.. (2013). Cryptococcose osseuse chez une patiente porteuse d’une leucémie lymphocytique traitée par fludarabine-cyclophosphamide-rituximab. Journal de Mycologie Médicale. 23(1). 57–63. 9 indexed citations
7.
Gouellec, N. Le, F. Ajana, Julien Poissy, et al.. (2010). Primo-infection toxoplasmique avec atteinte pulmonaire chez un immunocompétent. Médecine et Maladies Infectieuses. 40(12). 713–715. 4 indexed citations
8.
Hénard, Sandrine, L. Letranchant, F. Ajana, et al.. (2010). Étude des infections à VIH nouvellement découvertes entre 2000 et 2007 dans le Nord et l’Est de la France. Médecine et Maladies Infectieuses. 40(9). 517–523. 1 indexed citations
9.
Ajana, F.. (2006). L'hépatite virale B, encore et toujours d'actualité. Archives de Pédiatrie. 13(9). 1269–1274. 1 indexed citations
10.
Gérard, Y, Didier Hober, M. Assicot, et al.. (1997). Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. Journal of Infection. 35(1). 41–46. 57 indexed citations
11.
Senneville, É., Caroline O. S. Savage, Olivier Lamy, et al.. (1997). Failure of intravenous antibiotic therapy of multiple temporal brain abscesses due to Propionibacterium acnes requiring temporal lobectomy. Journal of Infection. 34(3). 269–271. 11 indexed citations
12.
Jouault, Thierry, et al.. (1997). Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans. Clinical and Diagnostic Laboratory Immunology. 4(3). 328–333. 17 indexed citations
13.
Chidiac, Christian, S. Alfandari, É. Senneville, et al.. (1994). Infections bactériennes chez les patients infectés par le VIH : l'expérience du CISIH France-Nord. Médecine et Maladies Infectieuses. 24. 723–727. 3 indexed citations
14.
Mouton, Y, O. Leroy, C. Beuscart, et al.. (1993). Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 31(suppl A). 87–95. 35 indexed citations
15.
Bournique, Bruno, et al.. (1992). Detection of HIV-1 infections by PCR: evaluation in a seropositive subject population. Molecular and Cellular Probes. 6(6). 443–450. 3 indexed citations
16.
Fortier, B, et al.. (1991). Toxoplasma gondii: 2 cas de recontamination sur terrain immun.. La Presse Médicale. 20(41). 2109–2109. 1 indexed citations
17.
Dei‐Cas, Eduardo, Eugénia Pinto, F. Ajana, et al.. (1991). Kinetic study of antifungal activity of amphotericin B, 5‐fluorocytosine and ketoconazole against clinical yeast isolates using liquid‐phase turbidimetry. Mycoses. 34(3-4). 167–172. 13 indexed citations
18.
Fortier, B, et al.. (1988). [Guillain-Barré syndrome with favorable outcome in a case of recent human immunodeficiency virus infection].. PubMed. 144(1). 32–5. 5 indexed citations
19.
Fortier, B, Patrick Delplace, Jean‐François Dubremetz, F. Ajana, & A. Vernes. (1987). Enzyme immunoassay for detection of antigen in acutePlasmodium falciparum malaria. European Journal of Clinical Microbiology & Infectious Diseases. 6(5). 596–598. 9 indexed citations
20.
Mouton, Y, Marie‐Jo Brion, F. Ajana, et al.. (1979). Frequency and severity of pneumococcal infections. Prevalence in the community population of the city of Tourcoing.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 70(3-4). 385–93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Ferguson Breakdown of academic impact, for papers by Andrea Bedini Breakdown of academic impact, for papers by Manuela Avolio Breakdown of academic impact, for papers by Concha Amador Breakdown of academic impact, for papers by Sadako Yoshizawa Breakdown of academic impact, for papers by José A. Bazan Breakdown of academic impact, for papers by J. Loutit Breakdown of academic impact, for papers by J. Colaert Breakdown of academic impact, for papers by Marco Libanore Breakdown of academic impact, for papers by H J Kolmos
Rankless by CCL
2026